William Morris, MD
Hospice and Palliative Medicine · Santa Cruz, CANPI 1720147150
Payments from drug & device makers
What this record shows
This record is dominated by other: $997 of the $1,364 with a category attached, or 73.1%. Novartis accounts for 77.0% of it on its own, with 10 other manufacturers making up the rest. Among hospice and palliative medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $52.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Johnson & Johnson$74
- Daiichi Sankyo Inc.$51
- Eisai Inc.$32
- Pharmaessentia USA Corporation$31
- Astellas Pharma US Inc$28
- plus $98 from 5 others
What the payments were for
- Food & beverage$36727%
- Other$99773%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 12 | $1,050 |
| Johnson & Johnson | 4 | $74 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Eisai Inc. | 1 | $32 |
| Pharmaessentia USA Corporation | 1 | $31 |
| Astellas Pharma US Inc | 1 | $28 |
| Merck | 1 | $24 |
| Genmab U.S., Inc. | 1 | $22 |
| Coherus Oncology, Inc. | 1 | $18 |
| Incyte Corporation | 1 | $17 |
| AstraZeneca | 1 | $16 |
How this compares
$1,364 in reported general payments places this provider in the 90th percentile of 195 hospice and palliative medicine providers in California.
See all hospice and palliative medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FanaptIloperidone | 26 | $21,768 |
| Buprenorphine Hcl | 462 | $16,033 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 155 | $15,515 |
| EliquisApixaban | 11 | $7,521 |
| Buprenorphine | 24 | $5,092 |
| Methadone Hcl | 147 | $4,590 |
| Sucralfate | 11 | $4,559 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 68 | $2,591 |
| Pregabalin | 128 | $1,958 |
| Morphine Sulfate ErMorphine Sulfate | 58 | $1,876 |
| Oxycodone Hcl | 82 | $1,758 |
| Gabapentin | 80 | $1,548 |
| LantusInsulin Glargine,hum.Rec.Anlog | 14 | $1,548 |
| Promethazine Hcl | 54 | $1,491 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 46 | $1,407 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Santa Cruz
- Sharon YeeArcadia$44K
- Neil SoniFountain Valley$28K
- Marietta Abalos-GalitoSan Jose$21K
- Humayon KhanSanta Ana$7K
- Sorin BugaDuarte$5K
- Glenn CarrFresno$5K
- Steven HarrisFoster City$5K
- Christopher PhillipsMurrieta$4K
- William DaleDuarte$3K
- Nehal PatelLaguna Hills$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.